Toulose, France Clinical Trials

A listing of Toulose, France clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 132 clinical trials
Adapting Treatment to the Tumor Molecular Alterations for Patients With Advanced Solid Tumors: My Own Specific Treatment

The MOST Plus study is a two-period phase II clinical trial, conducted in patients with all types of progressive solid tumors after at least 1 prior systemic treatment regimen for advanced disease (in the absence of a validated second line therapy). The main goal of this study is to evaluate …

Institut Bergoni
 (131.0 away) Contact site
  • 0 views
  • 11 Feb, 2021
  • +11 other locations
Study of the Safety and Efficacy of AMT-101 in Subjects With Pouchitis

Phase 2 Study Investigating the Efficacy of AMT-101 in Subjects with Chronic Antibiotic-resistant Pouchitis

CHU de Toulouse - H pital Rangueil
 (0.5 away) Contact site
  • 0 views
  • 13 Jun, 2021
  • +20 other locations
Trastuzumab Deruxtecan in Participants With HER2-overexpressing Advanced or Metastatic Colorectal Cancer

This study will evaluate the efficacy, safety, and pharmacokinetics of Trastuzumab deruxtecan (T-DXd) in participants with human epidermal growth factor 2 (HER2)-overexpressing locally advanced, unresectable, or metastatic colorectal cancer (mCRC).

CHU Toulouse
 (0.0 away) Contact site
  • 0 views
  • 20 Jun, 2021
  • +71 other locations
Surgery in Treating Patients With Neuroblastoma

RATIONALE: Surgery may be an effective treatment for neuroblastoma. PURPOSE: This phase II trial is studying how well surgery works in treating patients with neuroblastoma.

Centre Hospitalier Regional de Purpan
 (2.0 away) Contact site
  • 73 views
  • 07 Nov, 2020
  • +18 other locations
An Efficacy and Safety Study of Erdafitinib (JNJ-42756493) in Participants With Urothelial Cancer

The purpose of this study is to evaluate the objective response rate (complete response [CR]+ partial response [PR]) of the selected dose regimen in participants with metastatic or surgically unresectable urothelial cancers that harbor specific FGFR genomic alterations.

measurable disease
erdafitinib
renal function
adjuvant chemotherapy
dose regimen
Institut Bergoni
 (131.0 away) Contact site
  • 40 views
  • 29 May, 2021
  • +150 other locations
A Study to Evaluate the Efficacy and Safety of Pemigatinib (INCB054828) in Subjects With Myeloid/Lymphoid Neoplasms With FGFR1 Rearrangement - (FIGHT-203)

The purpose of this study is to evaluate the efficacy and safety of pemigatinib (INCB054828) in subjects with myeloid/lymphoid neoplasms with fibroblast growth factor receptor (FGFR) 1 rearrangement.

Centre L on B rard
 (222.8 away) Contact site
  • 272 views
  • 28 Jan, 2021
  • +75 other locations
A Clinical Study of to Confirm the Doses of Selexipag in Children With Pulmonary Arterial Hypertension

Selexipag is available for the treatment of pulmonary arterial hypertension (PAH) in adults in various countries. The efficacy of selexipag to delay disease progression was shown in a previous pivotal study conducted in 1156 adult patients with PAH. Given the similarities in the functional changes of PAH in children and …

hpah
heart disease
right heart catheterization
endothelin
selexipag
HOSP ARNAUD DE VILLENEUVE - PAED DEPT (Montpellier)
 (116.2 away) Contact site
  • 34 views
  • 26 Apr, 2021
  • +92 other locations
Efficacy and Safety of Pemigatinib in Previously Treated Locally Advanced/Metastatic or Surgically Unresectable Solid Tumor Malignancies Harboring Activating FGFR Mutations or Translocations (FIGHT-207)

The purpose of this study is to evaluate the efficacy and safety of pemigatinib in participants with previously treated locally advanced/metastatic or surgically unresectable solid tumor malignancies harboring activating FGFR mutations or translocations.

Institut Universitaire du Cancer de Toulouse Oncopole
 (0.5 away) Contact site
  • 50 views
  • 01 Apr, 2021
  • +122 other locations
A Study of IMR-687 in Subjects With Beta Thalassemia

A Study to Evaluate the Safety and Tolerability of IMR-687 in Subjects with Beta Thalassemia

cell transplantation
beta thalassemia
Institut Universitaire du Cancer de Toulouse Oncopole
 (0.5 away) Contact site
  • 10 views
  • 10 Jun, 2021
  • +38 other locations
Tislelizumab in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma

The primary objective of the study is to evaluate the efficacy of tislelizumab in participants with relapsed/refractory classical Hodgkin lymphoma, as measured by the overall response rate per the Lugano Classification, and as determined by the investigator.

chemotherapy regimen
measurable disease
lymphoma
brentuximab
refractory classical hodgkin lymphoma
CHU de Montpellier
 (120.4 away) Contact site
  • 0 views
  • 03 May, 2021
  • +22 other locations